EXIDEIND.NS(EXIDEIND.NS)
EXIDEIND.NS
No analyst ratings available
No analyst price targets available for EXIDEIND.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $189.73B | $204.28B | $216.14B | $236.97B |
| Low | $174.00B | $194.06B | $201.92B | $221.38B |
| High | $196.85B | $214.94B | $225.89B | $247.67B |
| EBITDA Avg | $20.96B | $22.57B | $23.87B | $26.18B |
| Low | $19.22B | $21.44B | $22.30B | $24.45B |
| High | $21.74B | $23.74B | $24.95B | $27.36B |
| EBIT Avg | $14.54B | $15.66B | $16.57B | $18.17B |
| Low | $13.34B | $14.88B | $15.48B | $16.97B |
| High | $15.09B | $16.48B | $17.32B | $18.99B |
| Net Income Avg | $12.49B | $14.38B | $15.97B | $22.01B |
| Low | $11.46B | $13.07B | $14.61B | $20.13B |
| High | $13.40B | $15.75B | $16.91B | $23.31B |
| EPS Avg | $14.69 | $16.92 | $18.79 | $25.90 |
| Low | $13.49 | $15.38 | $17.19 | $23.68 |
| High | $15.77 | $18.53 | $19.90 | $27.42 |
| Analysts (Rev / EPS) | 16 / 13 | 15 / 16 | 11 / 10 | 7 / 10 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $46.16B | $44.00B | $48.63B |
| Low | $45.13B | $43.01B | $47.54B |
| High | $47.20B | $44.99B | $49.73B |
| EBITDA Avg | $5.10B | $4.86B | $5.37B |
| Low | $4.98B | $4.75B | $5.25B |
| High | $5.21B | $4.97B | $5.49B |
| EBIT Avg | $3.54B | $3.37B | $3.73B |
| Low | $3.46B | $3.30B | $3.64B |
| High | $3.62B | $3.45B | $3.81B |
| Net Income Avg | $2.89B | $3.06B | $3.57B |
| Low | $2.56B | $2.97B | $3.47B |
| High | $3.23B | $3.15B | $3.68B |
| EPS Avg | $3.40 | $3.60 | $4.20 |
| Low | $3.01 | $3.49 | $4.08 |
| High | $3.79 | $3.71 | $4.32 |
| Analysts (Rev / EPS) | 2 / 2 | 1 / 1 | 1 / 1 |